Tempest Therapeutics, Inc. Increase (Decrease) in Interest Payable, Net
Tempest Therapeutics, Inc. (TPST) reported Increase (Decrease) in Interest Payable, Net of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2026-08-13
- Tempest Therapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2026-06-30 was $0.00.
- Tempest Therapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2026-03-31 was $0.00.
- Tempest Therapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2025-12-31 was $0.00.
- Tempest Therapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2025-09-30 was $0.00.
- Tempest Therapeutics, Inc. increase (decrease) in interest payable, net for fiscal 2025 was -$59.00K.
- Tempest Therapeutics, Inc. increase (decrease) in interest payable, net for fiscal 2024 was -$54.00K, a 437.50% decline from fiscal 2023.
- Tempest Therapeutics, Inc. increase (decrease) in interest payable, net for fiscal 2023 was $16.00K.
- Tempest Therapeutics, Inc. increase (decrease) in interest payable, net for fiscal 2022 was -$256.00K, a 378.26% decline from fiscal 2021.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | -$36.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | -$36.00K derived: sum of 3 quarters · filed 2026-08-13 | -$59.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$36.00K derived: sum of 2 quarters · filed 2026-08-13 | -$59.00K 10-Q · filed 2025-11-05 | -$83.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$59.00K 10-Q · filed 2026-08-13 | -$83.00K derived: sum of 3 quarters · filed 2026-08-13 | -$106.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$23.00K 10-Q · filed 2026-05-14 | -$47.00K derived: sum of 2 quarters · filed 2026-05-14 | -$70.00K derived: sum of 3 quarters · filed 2026-05-14 | -$74.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$47.00K derived: sum of 2 quarters · filed 2026-03-30 | -$51.00K derived: sum of 3 quarters · filed 2026-03-30 | -$54.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$27.00K derived: sum of 2 quarters · filed 2025-11-05 | -$30.00K 10-Q · filed 2025-11-05 | -$23.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$7.00K 10-Q · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2025-08-11 | $1.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$3.00K 10-Q · filed 2025-05-13 | $4.00K derived: sum of 2 quarters · filed 2025-05-13 | $5.00K derived: sum of 3 quarters · filed 2025-05-13 | $6.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $8.00K derived: sum of 2 quarters · filed 2025-03-27 | $9.00K derived: sum of 3 quarters · filed 2025-03-27 | $16.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.00K derived: sum of 2 quarters · filed 2024-11-12 | $9.00K 10-Q · filed 2024-11-12 | -$274.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.00K 10-Q · filed 2024-08-08 | -$275.00K derived: sum of 3 quarters · filed 2024-08-08 | -$257.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-09 | -$276.00K derived: sum of 2 quarters · filed 2024-05-09 | -$258.00K derived: sum of 3 quarters · filed 2024-05-09 | -$251.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$265.00K derived: sum of 2 quarters · filed 2024-03-19 | -$258.00K derived: sum of 3 quarters · filed 2024-03-19 | -$256.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $25.00K derived: sum of 2 quarters · filed 2023-11-08 | $27.00K 10-Q · filed 2023-11-08 | $30.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $9.00K 10-Q · filed 2023-08-10 | $12.00K derived: sum of 3 quarters · filed 2023-08-10 | $12.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-10 | $5.00K derived: sum of 2 quarters · filed 2023-05-10 | $5.00K derived: sum of 3 quarters · filed 2023-05-10 | $2.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.00K derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $92.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$3.00K derived: sum of 2 quarters · filed 2022-11-08 | $89.00K 10-Q · filed 2022-11-08 | $89.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $89.00K 10-Q · filed 2022-08-15 | $89.00K derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | $92.00K 10-Q · filed 2022-05-13 | $92.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |